Cargando…

Immune Mechanisms in Myelodysplastic Syndrome

Myelodysplastic syndrome (MDS) is a spectrum of diseases, characterized by debilitating cytopenias and a propensity of developing acute myeloid leukemia. Comprehensive sequencing efforts have revealed a range of mutations characteristic, but not specific, of MDS. Epidemiologically, autoimmune diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glenthøj, Andreas, Ørskov, Andreas Due, Hansen, Jakob Werner, Hadrup, Sine Reker, O’Connell, Casey, Grønbæk, Kirsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926477/ https://www.ncbi.nlm.nih.gov/pubmed/27314337 http://dx.doi.org/10.3390/ijms17060944

Ejemplares similares

Inflammatory Cytokine Profiles Do Not Differ Between Patients With Idiopathic Cytopenias of Undetermined Significance and Myelodysplastic Syndromes
por: Nielsen, Amalie Bach, et al.
Publicado: (2022)

LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome
por: Kaastrup, Katja, et al.
Publicado: (2023)

The antigen specific composition of melanoma tumor infiltrating lymphocytes?
por: Hadrup, Sine Reker
Publicado: (2012)

Comment on “5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity”
por: Frøsig, Thomas Mørch, et al.
Publicado: (2015)

MHC-based detection of antigen-specific CD8(+) T cell responses
por: Hadrup, Sine Reker, et al.
Publicado: (2010)

Evolution of MHC-based technologies used for detection of antigen-responsive T cells
por: Bentzen, Amalie Kai, et al.
Publicado: (2017)

T-cell-receptor cross-recognition and strategies to select safe T-cell receptors for clinical translation
por: Bentzen, Amalie Kai, et al.
Publicado: (2019)

“Immunotherapy of cancer: present status and future promise”: Danish Cancer Society Symposium, Copenhagen, Denmark, 23rd–25th September 2013
por: Donia, Marco, et al.
Publicado: (2014)

Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations
por: Aslan, Derya, et al.
Publicado: (2016)

Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers
por: Saini, Sunil Kumar, et al.
Publicado: (2020)

Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types
por: Araujo B. de Lima, Vinicius, et al.
Publicado: (2021)

T Cell Epitope Prediction and Its Application to Immunotherapy
por: Schaap-Johansen, Anna-Lisa, et al.
Publicado: (2021)

The Immune System Strikes Back: Cellular Immune Responses against Indoleamine 2,3-dioxygenase
por: Sørensen, Rikke Bæk, et al.
Publicado: (2009)

Dual pathology: Everolimus‐induced microangiopathic haemolytic anaemia in a patient with myelodysplastic syndrome
por: Nuttall Musson, Ellen, et al.
Publicado: (2022)

Neoantigen reactive T cells correlate with the low mutational burden in hematological malignancies
por: Saini, Sunil Kumar, et al.
Publicado: (2022)

Optimization in Detection of Antigen‐Specific T Cells Through Differentially Labeled MHC Multimers
por: Pedersen, Natasja Wulff, et al.
Publicado: (2019)

Improved T cell receptor antigen pairing through data-driven filtering of sequencing information from single cells
por: Povlsen, Helle Rus, et al.
Publicado: (2023)

Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study
por: Lauritsen, Tine Bichel, et al.
Publicado: (2022)

First Report of Severe Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplant in a Patient With Myelodysplastic Syndrome Treated With Atezolizumab: Literature Review
por: Hsiao, Mindy, et al.
Publicado: (2020)

Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients
por: Iversen, Trine Zeeberg, et al.
Publicado: (2013)

Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation
por: Ørskov, Andreas D., et al.
Publicado: (2015)

Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
por: Bjoern, Jon, et al.
Publicado: (2018)

Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
por: Bjoern, Jon, et al.
Publicado: (2017)

Immune dysregulation in myelodysplastic syndrome
por: Sugimori, Chiharu, et al.
Publicado: (2010)

The Danish Myelodysplastic Syndromes Database: Patient Characteristics and Validity of Data Records
por: Lauritsen, Tine Bichel, et al.
Publicado: (2021)

An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
por: Bjerregaard, Anne-Mette, et al.
Publicado: (2017)

Corrigendum: An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
por: Bjerregaard, Anne-Mette, et al.
Publicado: (2018)

Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learning
por: Sallman, David A., et al.
Publicado: (2022)

Mechanisms of Resistance to Decitabine in the Myelodysplastic Syndrome
por: Qin, Taichun, et al.
Publicado: (2011)

Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8(+) T cell immunity in CLL and MDS patients
por: Hernandez, Susana Patricia Amaya, et al.
Publicado: (2023)

Broadening the repertoire of melanoma-associated T-cell epitopes
por: Frøsig, Thomas Mørch, et al.
Publicado: (2015)

Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome Patients
por: Søgaard Helbo, Alexandra, et al.
Publicado: (2015)

Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes
por: Kouroukli, Olga, et al.
Publicado: (2022)

Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy
por: Tumas, Sarunas, et al.
Publicado: (2023)

Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: Normalization of plasma vitamin C induces epigenetic changes
por: Gillberg, Linn, et al.
Publicado: (2019)

Myelodysplastic syndromes
por: Hellström Lindberg, Eva
Publicado: (2018)

SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8(+) T cell activation in COVID-19 patients
por: Saini, Sunil Kumar, et al.
Publicado: (2021)

The Rising Era of Immune Checkpoint Inhibitors in Myelodysplastic Syndromes
por: Chokr, Nora, et al.
Publicado: (2018)

Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients
por: Votavova, Hana, et al.
Publicado: (2021)

Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Kapoor, Sargam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r0daoe3kca9rqhg1dhsokeui1g